BDR group

State Of The Art Facilities

about us

Explore BDR Pharmaceuticals

View All Programs
about us

Explore BDR Pharmaceuticals

Pioneering Pharmaceutical Excellence

In today’s dynamic global pharmaceutical market, BDR Pharmaceuticals has carved a niche for itself, with an avant-garde formulations portfolio for speciality medication. Their rich expertise and unique multi-branding strategy empower early identification, prompt development and smooth introduction of critical and lifesaving medicines, making them available to the masses at an affordable price.

Committed to pushing the boundaries of modern medicine, BDR Pharma’s stringent quality measures and cutting-edge production techniques ensure that all products meet or surpass the market benchmarks.

Read More
Innovative Medical Advances

Innovation forms the core of everything we do at BDR. From adopting new-age methodologies to putting in place novel delivery systems for existing molecules, to optimization of the existing formulations, BDR is daily pushing the boundaries of modern medicine.

Read More
Affordable Quality Medication

We at BDR aim to make affordable medication available to the masses without a compromise on quality. Our stringent quality measures ensure that all our products are at par or better than the best products available in the market. Our expert research and development team utilizes cutting edge production techniques to facilitate early introduction of new therapeutic molecules and preparation of advanced intermediates.

Read More
BDR group

A Research & development driven organization

First to Launch - We specialize in early identification, development And commercialization of complex molecules and affordable prices. We have a strong track record of 50+ product launches in the past decade.

intergrated-player-small
01

Integrated Player

Integrated Player

BDR is a fully integrated and complex generic player, seamlessly managing the entire value chain—from KSM materials and APIs to finished formulations, R&D, and marketing under its own brand.

first-to-launch-small
02

First-To-Launch

First-To-Launch

Specializes in early identification, development and launch of high-quality complex molecules at competitive prices

niche-therapy-small
03

Niche Therapy Areas

Niche Therapy Areas

Key therapies are Oncology and Critical Care with growing presence in Cardiology and Dermatology1

strong-presence-small
04

Global Player

Global Player

BDR is rapidly emerging as a global force, with a strong foothold in emerging markets and expanding presence in highly regulated markets. Fuelled by strategic export registrations and market access, the company has also forged key partnerships with some of the world's largest generic companies, reinforcing its position as a fast-growing player in the global pharmaceutical landscape.

product-launch-small
05

New Product Launches

New Product Launches

Demonstrated capability of achieving leadership position in key molecules, with clear pathway of launching 40+ molecules between FY22-25

management-team-small
06

Established Team

Established Team

Professional management and execution team, backed by a pool of 1,000+ employees, including 83 in R&D team

coivd-control-small
07

Strong Product Pipeline

Strong Product Pipeline

BDR boasts a robust product pipeline mapped out for the next decade, with a strategic focus on addressing critical therapeutic gaps in patient care. Prioritizing innovation and patient outcomes over business goals, BDR is committed to advancing treatments that meet the most pressing medical needs.

Inverted Commas
our strengths

differentiated approach

Blockbuster molecules

research-led innovation

Pioneer in developing and launching key molecules, supported by research-led innovation

Enzalutamide

  • Enzalutamide was a patented product prior to BDR launch
  • BDR was one of the few players to receive DCGI approval in 2017 after rejection of patents in 2016
  • BDR was the first player to launch Enzalutamide in 2017, making it the first generic version in the world market
  • Since the launch, BDR has been able to scale up the molecule, garnering > 70% market share in the process

Abiraterone

  • Initially, Abiraterone had a poor market penetration on account of non-affordability and unavailability
  • BDR launched the product in 2013 at a significantly low price, thus making the drug affordable and available
  • Developed and introduced a new delivery system
  • BDR garnered > 60% market share in the process

Caspofungin

  • Caspofungin was the first successful launch in Antifungal market and continues to be the leader in that segment (widely used in Onco, Critical Care, Derma, HIV segments)
  • BDR is the first Indian company to introduced this, after Merck
  • Within a year of launch, BDR was able to sell large volumes of injections
  • BDR continues to be the leader in antifungal segment, controlling 70% market share
  • Acceptance level has increased amongst the doctors (used as a substitute of Lip. Amphotericin B in few covid cases)

Nintedanib

  • An effective fibrosis treatment molecule in Covid and a preferred brand for out-patient clinics
  • Nintedanib has a lifelong use for treatment of chronic disease
  • BDR is the first Indian company to launch this after Boehringer Ingelheim, with complete backward integration capability

Liposomal Amphotericin B

  • Being a highly complex product, BDR was the earliest players to develop and launch the product
  • Product has been approved post Clinical trial and comparative analysis with Innovator
  • BDR relaunched the drug in 2021. Has established itself as a sole supplier and preferred partner with state government for treatment of Mucormycosis
  • Within 2 months of launch, BDR has was able to see large volume of injectables with robust order pipeline
clients

our trusted clients

We believe in not just providing a service to our clients but forming a relationship based on understanding our client's needs

Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
Client Name
our news

latest News and update

Keep up with the latest news, updates and activities of BDR Pharma.

know more about our innovation & development capabilities

Click Here